Optimizing the Tobacco Cessation Clinical Decision Support Tool.
NCT ID: NCT03714191
Last Updated: 2021-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54417 participants
OBSERVATIONAL
2018-10-03
2020-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Lung Screening, Tobacco and Health Project
NCT03200236
Smoking Cessation Intervention
NCT03072511
Switching to Reduced Oxidant or Nicotine Content Cigarettes in Smokers
NCT02415270
Nicotine Replacement Provided at a Tertiary Care Hospital
NCT01614054
De-nicotinised Cigarettes Study
NCT01250301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Improved outcomes
Patient Outcomes
The intervention includes different versions of the BPA design and message.
Regulatory reminder
Regulatory
The intervention includes different versions of the BPA design and message.
Billing and documentation
Billing documentation
The intervention includes different versions of the BPA design and message.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient Outcomes
The intervention includes different versions of the BPA design and message.
Billing documentation
The intervention includes different versions of the BPA design and message.
Regulatory
The intervention includes different versions of the BPA design and message.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Austrian J, Mendoza F, Szerencsy A, Fenelon L, Horwitz LI, Jones S, Kuznetsova M, Mann DM. Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials. J Med Internet Res. 2021 Apr 9;23(4):e16651. doi: 10.2196/16651.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QI-Tobacco Cessation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.